News: Medicine

View:

2003

 

Found press releases

 

Exanta (ximelagatran) receives first approval

12/23/2003 10:25 AM EST  -   AstraZeneca
PublishPublishEXANTA (XIMELAGATRAN) RECEIVES FIRST APPROVAL

First indication for prevention of venous thromboembolic
events in major orthopaedic surgery

AstraZeneca has received its first regulatory approval for
ExantaTM (ximelagatran) in France for the prevention of
venous thromboembolic events in major orthopaedic (hip or
knee replacement) surgery. France is the Reference...

Q-Med has received the second payment of $53,3 million from Medicis

12/19/2003 3:23 AM EST  -   Q-Med
With reference to that the American regulatory authority, Food And Drug Administration, FDA, has approved RESTYLANE for sales in USA, Q-Med has now received $53,3 million from Medicis. Of this amount $1 million will be paid to the financial advisor.

At the beginning of March Q-Med received a first payment of USD 58.2 million. A payment of USD 29.1 million is due after sales approval of RESTYLANE Perlane....

Micronic Receives Order for LRS Series Laser Writer for Advanced TFT-LCD Photoma...

12/18/2003 6:12 AM EST  -   Micronic
Taby, Sweden - December 18, 2003 - Micronic Laser Systems AB (Stockholmsbörsen's Attract 40: MICR), a leading manufacturer of laser pattern generation equipment to the display and semiconductor industries, today announced an order for an LRS11000 series pattern generation tool for advanced TFT-LCD display photomasks from an Asian customer. The system is expected to ship during the second half of 2004.

"We...

New Head of Investor Relations at Nobel Biocare

12/16/2003 3:58 AM EST  -   Nobel Biocare
As of January 5, 2004 Suha Demokan (37) will join Nobel Biocare as the
Head of Investor Relations. The Investor Relations function will be
enhanced to address the increasing needs of stock exchanges,
shareholders, investors, financial analysts and the media. This function
will report directly to the Chief Executive Officer Heliane Canepa.

Suha Demokan has been with Centerpulse AG in...

Head of Marketing and Business Development Strengthens Biacore's Executive Manag...

12/15/2003 6:00 AM EST  -   Biacore
Head of Marketing and Business Development
Strengthens Biacore's Executive Management Team

Uppsala, Sweden, December 15, 2003. Biacore International AB (Biacore)
(Stockholmsbörsen: BCOR; Nasdaq: BCOR) today announced the decision to
establish a new position, Head of Marketing and Business Development,
reporting to the President and Chief Executive...

Orexo Pharmaceuticals elects Håkan Åström as new Chairman of the Board

12/15/2003 6:00 AM EST  -   Orexo
Orexo AB in Uppsala today announces the election of Zsolt Lavotha, Kjell Strandberg and Håkan Åström as new members of the Board of Directors. The elections were made at Orexo's extra shareholders meeting on December 11.

Håkan Åström was appointed new Chairman of the Board at the subsequent board meeting on December 12.

"The new board members brings significant pharmaceutical business...

RESTYLANE approved for sales in USA

12/12/2003 6:12 PM EST  -   Q-Med
The FDA (Food and Drug Administration), the American regulatory authority, has approved RESTYLANE for sales in USA.

The FDA's approval of RESTYLANE means that Q-Med will receive the second payment of USD 53.3 million from the American company Medicis, which has held the rights to sell and market RESTYLANE in USA and Canada since March.

"RESTYLANE is the only non-animal hyaluronic acid based...

Elekta helps build advanced healthcare in Iraq

12/11/2003 4:40 AM EST  -   Elekta
ELEKTA HELPS BUILD ADVANCED HEALTHCARE IN IRAQ

Through United Nation's oil-for-food program, which also has been part
of the reconstruction of Iraq, Elekta has been chosen to deliver
complete systems for minimal-invasive stereotactic and functional
neurosurgery to be installed at hospitals in various parts of Iraq. The
delivery, carried out in October and with a value of approx. EUR...

Micronic Names Kjell Bohlin Chief Technical Officer

12/11/2003 3:18 AM EST  -   Micronic
Täby, Sweden - December 11, 2003 - Micronic Laser Systems AB (Stockholmsbörsen's Attract 40: MICR), a leading manufacturer of laser pattern generation equipment to the display and semiconductor industries, has named Kjell Bohlin, Ph.D to the position of chief technical officer, and member of Micronic's Corporate Management Team.

Dr. Bohlin assumes overall responsibility for Micronic's technical...

ZUIDEX obtains reimbursement in German hospitals

12/9/2003 11:03 AM EST  -   Q-Med
The German authorities have decided that treatment by injection for
urinary incontinence shall be included in the so-called Diagnosis
Related Groups system (DRG) during 2004.

Zuidex, which is Q-Med's product for the treatment of stress urinary
incontinence in women, will therefore be included in this refund system
as from January 1, 2004.

The fact that this form of...